Skip to Content


Active Substance: ibandronic acid
Common Name: ibandronic acid
ATC Code: M05BA06
Marketing Authorisation Holder: Roche Registration Ltd.
Active Substance: ibandronic acid
Status: Withdrawn
Authorisation Date: 1996-06-25
Therapeutic Area: Hypercalcemia Cancer
Pharmacotherapeutic Group: Drugs for treatment of bone diseases

Therapeutic Indication

Treatment of tumour-induced hypercalcaemia with or without metastases.

The marketing authorisation for Destara has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.